Author:
Kamble Sarika M.,Patil Chandragouda R.
Funder
Science and Engineering Research Board
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference41 articles.
1. Blum, R. H., & Carter, S. K. (1974). A new drug with significant clinical activity. Annals of Internal Medicine, 80, 249–256.
2. Mohan, M., Kamble, S., Ghadi, P., & Kastrure, S. (2010). Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats. Food and Chemical Toxicology, 48, 436–440.
3. Aluise, C. D., Miriyal, S., Noel, T., Sultana, R., Jungsuwadee, P., Taylor, T. J., et al. (2011). 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biology and Medicine, 50, 1630–1638.
4. Tacar, O., Sriamornsak, P., & Dass, C. R. (2012). Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. Journal of Pharmacy and Pharmacology, 65, 157–170.
5. Cecen, E., Dost, T., Culhac, N., Karul, A., Ergur, B., & Birincioglu, M. (2011). Protective effect of sylimerin on doxorubicin-induced toxicity. Asian Pacific Journal of Cancer Prevention, 12, 2697–2704.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献